Early Human Development
Volume 86, Issue 2 , Pages 99-105, February 2010

Antenatal fetal VEGF therapy to promote pulmonary maturation in a preterm rabbit model

  • A. Debeer

      Affiliations

    • Centre for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium
    • University Hospitals Leuven, Department of Women and Child, Leuven, Belgium
    • Corresponding Author InformationCorresponding author. Neonatal Intensive Care Unit, University Hospital Gasthuisberg, Herestraat 49, B-3000 Leuven, Belgium. Tel.: +32 16 343211; fax: +32 16 343209.
  • ,
  • L. Sbragia

      Affiliations

    • Centre for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium
  • ,
  • K. Vrancken

      Affiliations

    • Centre for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium
  • ,
  • A. Hendriks

      Affiliations

    • Centre for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium
  • ,
  • X. Roubliova

      Affiliations

    • Centre for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium
  • ,
  • J. Jani

      Affiliations

    • Centre for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium
  • ,
  • G. Naulaers

      Affiliations

    • University Hospitals Leuven, Department of Women and Child, Leuven, Belgium
  • ,
  • P. Carmeliet

      Affiliations

    • Vesalius Research Center, VIB, Leuven, Belgium
    • Vesalius Research Center, KU Leuven, Leuven, Belgium
  • ,
  • J. Deprest

      Affiliations

    • Centre for Surgical Technologies, Faculty of Medicine, KU Leuven, Leuven, Belgium
    • University Hospitals Leuven, Department of Women and Child, Leuven, Belgium

Received 4 November 2009; received in revised form 18 January 2010; accepted 31 January 2010.

Abstract 

Aim

To assess the effects of fetal tracheal administration of VEGF on pulmonary maturation in a preterm rabbit model.

Methods

On day 26 (term=31days), fetal rabbits received recombinant rat VEGF (30µg in 70µL normal saline) or placebo (normal saline 70µL) intratracheally, with or without subsequent tracheal occlusion. Non-operated littermates served as internal controls. Fetuses were harvested on day 28 for morphometric study of the lungs or for mechanical ventilation and measurement of lung mechanics. In total, 96 fetuses from 42 does were used, 47 for ventilation and 49 for morphometry.

Results

In fetuses receiving intratracheal VEGF, an increase in immunoreactivity for Flk-1 was observed throughout the lung parenchyma. Tracheal occlusion (TO) adversely affected pulmonary mechanics as compared to un-occluded controls. That effect is partly reversed by intratracheal VEGF. Intratracheal injection of VEGF without tracheal occlusion improves lung mechanics but no more than what was observed in placebo injected controls.

Conclusion

Antenatal intratracheal VEGF administration was associated with an increase in Flk-1 immunoreactivity. It also improves lung mechanics, however more so when the trachea is occluded. Without TO, the effects were comparable to placebo controls.

Keywords: VEGF, Lung development, Lung mechanics

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 31.50 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.
 

PII: S0378-3782(10)00036-8

doi:10.1016/j.earlhumdev.2010.01.025

Early Human Development
Volume 86, Issue 2 , Pages 99-105, February 2010